RIL
CGEM icon

Rothschild Investment LLC’s Cullinan Oncology CGEM Stock Holding History

Rothschild Investment LLC’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61K Buy
253
+64
+34% +$950 ﹤0.01% 2325
2026
Q1 		$2.69K Buy
189
+156
+473% +$2K ﹤0.01% 2403
2025
Q4 		$342 Buy
33
+3
+10% +$27 ﹤0.01% 3018
2025
Q3 		$178 Hold
30
– – ﹤0.01% 3016
2025
Q2 		$226 Sell
30
-215
-88% -$1.73K ﹤0.01% 2919
2025
Q1 		$1.85K Buy
+245
New +$2.35K ﹤0.01% 1943
2024
Q4 		– Sell
-60
Closed -$1K – 2972
2024
Q3 		$1K Buy
60
+35
+140% +$621 ﹤0.01% 2167
2024
Q2 		$436 Buy
+25
New +$532 ﹤0.01% 2105

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Rothschild Investment LLC's CGEM Position: Q2 2026 in Review

Rothschild Investment LLC increased its Cullinan Oncology (CGEM) stake by 34% in Q2 2026, buying an estimated $950 and bringing the position to 253 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Rothschild Investment LLC first reported a position in CGEM in Q2 2024 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Rothschild Investment LLC held 253 shares of Cullinan Oncology worth $4.61K as of Q2 2026.
  • Rothschild Investment LLC bought 64 Cullinan Oncology shares in Q2 2026, an estimated $950.
  • Cullinan Oncology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2325 holding.
  • Rothschild Investment LLC first reported a position in Cullinan Oncology in Q2 2024 and has held it in 8 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.